| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/01/2014 | CN103483443A Recombinant human interferon-like proteins |
| 01/01/2014 | CN103483442A Mass spectrum model for detecting decayed tooth protein and construction method |
| 01/01/2014 | CN103483441A Rhesus monkey NY-ESO-1 protein, coding gene, and applications thereof |
| 01/01/2014 | CN103483440A Fish-source anti-freezing polypeptide and preparation method thereof |
| 01/01/2014 | CN103483439A Alpha O-superfamily conotoxin peptide, and medicinal composition and use thereof |
| 01/01/2014 | CN103483438A Gene for cadmium pollution remediation of plant soil and coded protein and application thereof |
| 01/01/2014 | CN103483437A Protein of key gene ApCO for photoperiod and flowering pathway of agapanthus praecox ssp.orientalis as well as coding gene and probe of gene |
| 01/01/2014 | CN103483436A Common buckwheat DREB (Dehydration Responsive Element Binding protein) transcription factor |
| 01/01/2014 | CN103483435A Gene cluster participating in synthesis of cucumber cucurbitacine C and application thereof |
| 01/01/2014 | CN103483434A Mycobacterium tuberculosis secretory antigen Mce3E and application thereof |
| 01/01/2014 | CN103483433A Novel effective cerecidin and application thereof |
| 01/01/2014 | CN103483432A Signal peptide optimizing efficient secretory expression of Savinase and application thereof |
| 01/01/2014 | CN103483431A Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications |
| 01/01/2014 | CN103483430A Application of protein A1G_07050 to Rickettsia rickettsii-resisting immunoprotection |
| 01/01/2014 | CN103483429A Core structural domain of VirB protein, and coding genes and applications thereof |
| 01/01/2014 | CN103483428A Small molecule-polypeptide conjugate capable of inhibiting HIV infection |
| 01/01/2014 | CN103483424A Thiopeptide precursor protein, gene encoding it and uses thereof |
| 01/01/2014 | CN103483421A Polypeptide used for treating HBV infection and related diseases, and antibodies thereof |
| 01/01/2014 | CN102786587B Transcription factor for improving plant seed aliphatic acid content and application thereof |
| 01/01/2014 | CN102781955B Bt protein Cry4Cb2, encoding gene of same and use thereof |
| 01/01/2014 | CN102690771B Functional lactobacillus plantarum and application thereof |
| 01/01/2014 | CN102657864B Immune adjuvant of foot-and-mouth disease vaccine and application of immune adjuvant |
| 01/01/2014 | CN102657849B Application of toad maggot protein in medicine used for treating cervical cancer |
| 01/01/2014 | CN102657848B Application of toad maggot protein in preparing medicine used for treating colon cancer |
| 01/01/2014 | CN102633869B Low temperature resistance associated protein and encoding gene and application thereof |
| 01/01/2014 | CN102558321B Protein AtLPT4 related to deficient-phosphorus stress tolerance of plants, and coding gene and application thereof |
| 01/01/2014 | CN102512662B Protein containing 36-83 amino acid motifs in Coxsackie B3virus 2B protein and application thereof |
| 01/01/2014 | CN102512661B Protein containing 1st to 79th sites of amino acid basic sequences in protein 2C of coxsackievirus B3 and application for same |
| 01/01/2014 | CN102512660B Protein containing 51st to 89th sites of amino acid basic sequences in protein 3A of coxsackievirus B3 and application for same |
| 01/01/2014 | CN102477092B Protein used for controlling anthocyanidin content, coding gene thereof, and application thereof |
| 01/01/2014 | CN102360013B ELISA kit for detecting duck plague virus antibody, and antibody detection method thereof |
| 01/01/2014 | CN102286092B Solid-phase synthesis method of liraglutide |
| 01/01/2014 | CN102239179B Integrin peptide, anti-cd 18 beta A antibody for treatment of endotoxin-mediated pro-inflammatory responses and the use |
| 01/01/2014 | CN102180965B Carbamazepine immunogen, anti-carbamazepine specific antibody, detection reagent and detection kit |
| 01/01/2014 | CN101809153B Factor involved in latent infection with herpesvirus, and use thereof |
| 01/01/2014 | CN101001646B Stabilized synthetic immunogen delivery system |
| 12/31/2013 | US8618374 Maize variety hybrid 10856790 |
| 12/31/2013 | US8618373 Maize variety hybrid 10854130 |
| 12/31/2013 | US8618357 Sweetpotato SRD1 cDNA and transgenic plants with high-numbered storage roots using the same |
| 12/31/2013 | US8618355 Aromatic prenyltransferase from hop |
| 12/31/2013 | US8618354 Generation of haploid plants and improved plant breeding |
| 12/31/2013 | US8618276 Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues |
| 12/31/2013 | US8618266 Hasylated polypeptides |
| 12/31/2013 | US8618263 Antibodies against tissue factor pathway inhibitor (TFPI) |
| 12/31/2013 | US8618262 Monoclonal antibodies against dendritic cell receptor |
| 12/31/2013 | US8618258 Freeze-dried fibrin matrices and methods for preparation thereof |
| 12/31/2013 | US8618257 Modified human plasma polypeptide or Fc scaffolds and their uses |
| 12/31/2013 | US8618256 Cysteine variants of interferon gamma |
| 12/31/2013 | US8618255 Spider silk proteins and methods for producing spider silk proteins |
| 12/31/2013 | US8618254 Inhibition of AXL signaling in anti-metastatic therapy |
| 12/31/2013 | US8618250 Designer collagens and use thereof |
| 12/31/2013 | US8618084 Aldosterone induced vascular elastin production |
| 12/31/2013 | US8618062 Method of modulating integrin mediated cellular activity and agents useful for same |
| 12/31/2013 | US8618059 Methods for treating reperfusion injuries using flagellin |
| 12/31/2013 | US8618053 FGF21 mutants multimers and uses thereof |
| 12/31/2013 | US8618052 Method of treating coronary artery disease by administering FGF-5 |
| 12/31/2013 | US8618051 Vesiculins |
| 12/31/2013 | US8618049 Ester insulin |
| 12/31/2013 | US8618045 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same |
| 12/31/2013 | US8618044 Thrombopoietic compounds |
| 12/31/2013 | US8618024 Nucleic acid binding polypeptide library |
| 12/31/2013 | US8617888 Bacterial mediated delivery of nuclear protein into pluripotent and differentiated cells |
| 12/31/2013 | US8617844 Use of cytokine receptors as biomarkers and therapeutic targets in human cancer |
| 12/31/2013 | US8617843 Recombinant peptide production using a cross-linkable solubility tag |
| 12/31/2013 | US8617841 Protein and production process and use thereof |
| 12/31/2013 | US8617837 Method of hydrolyzing soluble starch with an alpha-amylase variant |
| 12/31/2013 | US8617822 Method of inhibiting binding or activity of MIF by administering a MIF antagonist |
| 12/31/2013 | US8617821 Assay method for peptide specific T-cells |
| 12/31/2013 | US8617807 Nucleic acid binding proteins |
| 12/31/2013 | US8617613 Polymer-based sustained release device |
| 12/31/2013 | US8617575 Methods for conferring immunity against protozoans in an animal |
| 12/31/2013 | US8617574 Nontypable Haemophilus influenzae antigens |
| 12/31/2013 | US8617573 Botulinum neurotoxin B receptors and use thereof |
| 12/31/2013 | US8617565 Surface exposed Haemophilus influenzae protein (protein E; pE) |
| 12/31/2013 | US8617560 Peptides for vaccination against human CMV |
| 12/31/2013 | US8617553 Use of goat serum for veterinary treatment |
| 12/31/2013 | US8617551 Methods of diagnosing pancreatic inflammation by using chemokine PANEC-1 antibodies |
| 12/31/2013 | US8617532 Therapeutic use of interferon-polymer conjugates |
| 12/31/2013 | US8617531 Methods of making proteins and peptides containing a single free cysteine |
| 12/31/2013 | CA2722364C Melanoma antigens |
| 12/31/2013 | CA2670879C Method for evaluating obesity controller |
| 12/31/2013 | CA2596683C Conjugation of streptococcal capsular saccharides |
| 12/31/2013 | CA2588573C Immunotherapeutic formulations to generate autoantibodies capable to avoid the binding of interleukin-2 to its receptor their use in the treatment of cancer |
| 12/31/2013 | CA2548454C Medicament comprising recombinant antibody against chemokine receptor ccr4 |
| 12/31/2013 | CA2543257C Methods and compositions for delivering polynucleotides |
| 12/31/2013 | CA2542269C Fusion molecules comprising antigens and mhc i or ii cytoplasmic domains |
| 12/31/2013 | CA2523001C Therapeutic use of anti-cs1 antibodies |
| 12/31/2013 | CA2485847C Glucan-based vaccines |
| 12/31/2013 | CA2478371C Compositions and methods for generating an immune response |
| 12/31/2013 | CA2467908C Mfg-e8-l regulates phagocytic removal of apoptotic cells by macrophages |
| 12/31/2013 | CA2426030C Methods of treating disorders related to apoe |
| 12/31/2013 | CA2246768C Uses of gdnf and gdnf receptor |
| 12/27/2013 | WO2013192545A1 Compositions and methods for mediating plant stomatal development in response to carbon dioxide and applications for engineering drought tolerance in plants |
| 12/27/2013 | WO2013192504A1 Novel vista-ig constructs and the use of vista-ig for treatment of autoimmune, allergic and inflammatory disorders |
| 12/27/2013 | WO2013192130A1 Analogs of glucagon exhibiting gip receptor activity |
| 12/27/2013 | WO2013192129A1 Glucagon analogs exhibiting gip receptor activity |
| 12/27/2013 | WO2013192030A1 Humanized il-7 rodents |
| 12/27/2013 | WO2013191280A1 Agent for treating or preventing systemic inflammatory response syndrome |
| 12/27/2013 | WO2013191225A1 Mucosal immunity-stimulating agent, and oral pharmaceutical composition for treating hpv infection |
| 12/27/2013 | WO2013191173A1 Sample dispensing apparatus, crystallization method for protein, and microplate formation sheet |